OSCR

Pre- and Post-synapses Contain Lecanemab-reactive Amyloid-β in Post-mortem Human Alzheimer’s Disease Brain

Overview

  1. Institute for Neuroscience and Cardiovascular Research, The University of Edinburgh, UK
  2. UK Dementia Research Institute, University of Edinburgh, UK
  3. Leuven Brain Institute VIB-KU Leuven, Belgium
  4. UK Dementia Research Institute, University College London, UK
Institutions: University of Edinburgh (United Kingdom); UK Dementia Research Institute (United Kingdom); KU Leuven (Belgium); University College London (United Kingdom)
Dates: published online 18 May 2026
Type: Preprint
License: CC BY
Identifiers: DOI 10.64898/2026.05.08.26352549 · OpenAlex W7161567473
Open access: green, a free copy (OpenAlex)
Status: code verified (how the code is found and verified)
Categories: histology / microscopy (modality), human (organism), Alzheimer's / dementia (population), cellular / molecular (subfield)
Methods: Statistics
Keywords: Lecanemab, Synapses, Amyloid-b, Alzheimer’s Disease, Immunohistochemistry
Topic: Alzheimer's disease research and treatments (Cellular and Molecular Neuroscience, Neuroscience), according to OpenAlex
Funding: Wellcome Trust (218493/Z/19/Z)
Citations: not cited yet (Europe PMC); 26 references in the paper

Abstract

Recently, the amyloid-beta (Aβ) targeting antibody lecanemab has demonstrated modest therapeutic efficacy in slowing cognitive decline in people with Alzheimer’s disease (AD). Lecanemab clears amyloid plaques from the brain; however, plaque load does not correlate strongly with cognitive function. The strongest neuropathological correlate of cognitive decline in AD is synapse loss, which is exacerbated in the halo surrounding neuritic amyloid plaques where Ab accumulates in remaining synapses. Here, we hypothesised that, through clearing plaques and the associated halo of soluble Aβ that can directly damage synapses, lecanemab could temper plaque-associated synapse loss. High-resolution imaging of temporal cortex tissue from people who died with AD (N=20) and age-matched controls (N=19) reveals lecanemab staining within individual pre and post-synaptic excitatory terminals in addition to plaque staining. The percentage of pre-synapses containing lecanemab-positive Aβ was over 200% higher in AD and the percentage of post-synapses was over 150% higher in AD than control tissue, with highest levels of synaptic lecanemab staining observed near plaques. These data demonstrate that lecanemab antibody recognises Aβ within synapses, warranting future work to determine whether lecanemab treatment slows cognitive decline, at least in part, through both clearing plaques and facilitating clearance or neutralisation of synaptic Aβ.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

No file of the authors' code could be read here: it is described below, and read at its source.

datashare.ed.ac.uk/handle/10283

License: none: the authors keep all their rights
State: the link answers, verified on 28 October 2026
Evidence: the link answers
Software Heritage: not checked
Found in: “Data availability”
Not found: README, license file, CITATION.cff, environment file, tests, continuous integration, documentation
Availability: 2 checks, the latest on 28 October 2026: the link answers (HTTP 200)
  • 28 October 2026: the link answers (HTTP 200)
  • 28 September 2026: the link answers (HTTP 200)

The paper's code and data availability statement is in the Data section.

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 0 scripts, each with its path and the digest of its content;
  • no match between paragraphs and code yet;
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

No dataset and no data link were found in the paper.

Data availability

All spreadsheets and analysis scripts from the final accepted manuscript will be available on Edinburgh DataShare (https://datashare.ed.ac.uk/handle/10283/3076 DOI for these data to be added after peer review). Raw images are available from the corresponding author.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Authors: added Colin Smith (0000-0002-4507-5132); Bart De Strooper (0000-0001-5455-5819); removed Colin Smith; Bart De Strooper

Version 1, 28 September 2026: the first record

Recorded: type, journal, dates, 9 authors, 5 keywords, 1 funder, 26 references.

Cite

This paper

Holt, K., Chang, Y. Y., Li, M., Albertini, G., Smith, C., Tulloch, J., De Strooper, B., Hardingham, G. E., & Spires-Jones, T. L. (2026). Pre- and Post-synapses Contain Lecanemab-reactive Amyloid-β in Post-mortem Human Alzheimer’s Disease Brain. medRxiv (preprint). https://doi.org/10.64898/2026.05.08.26352549

BibTeX

@article{holt2026pre,
author = {Holt, Kristjan and Chang, Ya Yin and Li, Mosi and Albertini, Giulia and Smith, Colin and Tulloch, Jane and De Strooper, Bart and Hardingham, Giles E. and Spires-Jones, Tara L.},
title = {{Pre- and Post-synapses Contain Lecanemab-reactive Amyloid-β in Post-mortem Human Alzheimer’s Disease Brain}},
journal = {medRxiv (preprint)},
year = {2026},
month = may,
publisher = {medRxiv},
doi = {10.64898/2026.05.08.26352549},
url = {https://doi.org/10.64898/2026.05.08.26352549}
}

RIS

TY - JOUR
AU - Holt, Kristjan
AU - Chang, Ya Yin
AU - Li, Mosi
AU - Albertini, Giulia
AU - Smith, Colin
AU - Tulloch, Jane
AU - De Strooper, Bart
AU - Hardingham, Giles E.
AU - Spires-Jones, Tara L.
TI - Pre- and Post-synapses Contain Lecanemab-reactive Amyloid-β in Post-mortem Human Alzheimer’s Disease Brain
T2 - medRxiv (preprint)
J2 - medRxiv
PY - 2026
DA - 2026/05/18
PB - medRxiv
DO - 10.64898/2026.05.08.26352549
UR - https://doi.org/10.64898/2026.05.08.26352549
ER -

CSL-JSON

{
"id": "10.64898/2026.05.08.26352549",
"type": "article",
"title": "Pre- and Post-synapses Contain Lecanemab-reactive Amyloid-β in Post-mortem Human Alzheimer’s Disease Brain",
"container-title": "medRxiv (preprint)",
"author": [
{
"family": "Holt",
"given": "Kristjan"
},
{
"family": "Chang",
"given": "Ya Yin"
},
{
"family": "Li",
"given": "Mosi"
},
{
"family": "Albertini",
"given": "Giulia"
},
{
"family": "Smith",
"given": "Colin"
},
{
"family": "Tulloch",
"given": "Jane"
},
{
"family": "De Strooper",
"given": "Bart"
},
{
"family": "Hardingham",
"given": "Giles E."
},
{
"family": "Spires-Jones",
"given": "Tara L."
}
],
"container-title-short": "medRxiv",
"DOI": "10.64898/2026.05.08.26352549",
"publisher": "medRxiv",
"URL": "https://doi.org/10.64898/2026.05.08.26352549",
"issued": {
"date-parts": [
[
2026,
5,
18
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41593-025-01992-5
Evidence for trans-synaptic propagation of oligomeric tau in human progressive supranuclear palsy.
Journal: Nature neuroscience
In common: cellular / molecular, 4 references, 4 authors
[2] doi:10.1038/s41467-025-58879-z [code]
Divergent actions of physiological and pathological amyloid-β on synapses in live human brain slice cultures.
Journal: Nature communications
In common: Alzheimer's / dementia, cellular / molecular, 4 references, 3 authors
[3] doi:10.1002/alz.12894 [code]
Synaptic resilience is associated with maintained cognition during ageing.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
In common: histology / microscopy, Alzheimer's / dementia, 4 references, 3 authors
[4] doi:10.1111/ejn.70480 [code]
Astrocyte Proximity Protects Synapses From Human Amyloid-Beta Induced Degeneration in a Mouse Ex Vivo Model of Early Alzheimer's Disease.
Journal: The European journal of neuroscience
In common: histology / microscopy, Alzheimer's / dementia, cellular / molecular, 10 references, author Tara L. Spires-Jones
[5] doi:10.1007/s00401-023-02679-6 [code]
Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease.
Journal: Acta neuropathologica
In common: Alzheimer's / dementia, cellular / molecular, 6 references, 2 authors
[6] doi:10.1007/s00401-023-02667-w [code]
p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003.
Journal: Acta neuropathologica
In common: Alzheimer's / dementia, cellular / molecular, 2 references, 3 authors
[7] doi:10.1038/s41467-021-27702-w [code]
Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology.
Journal: Nature communications
In common: Alzheimer's / dementia, cellular / molecular, 2 references, 3 authors
[8] doi:10.1111/ejn.70180 [code]
Amyloid-Beta Pathology Increases Synaptic Engulfment by Glia in Feline Cognitive Dysfunction Syndrome: A Naturally Occurring Model of Alzheimer's Disease.
Journal: The European journal of neuroscience
In common: histology / microscopy, Alzheimer's / dementia, cellular / molecular, 8 references, author Tara L. Spires-Jones
[9] doi:10.1177/23982128221086464 [code]
Reducing voltage-dependent potassium channel Kv3.4 levels ameliorates synapse loss in a mouse model of Alzheimer's disease.
Journal: Brain and neuroscience advances
In common: Alzheimer's / dementia, cellular / molecular, 4 references, 2 authors
[10] doi:10.1523/eneuro.0306-22.2022 [code]
Microglial Expression of the Wnt Signaling Modulator <i>DKK2</i> Differs between Human Alzheimer's Disease Brains and Mouse Neurodegeneration Models.
Journal: eNeuro
In common: Alzheimer's / dementia, cellular / molecular, 4 references, author Bart De Strooper

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Add the badge to the code's README

OSCR: the badge of this paper

If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.

Markdown
<!-- oscr-badge:start -->
[![OSCR](https://openscicode.org/badge/doi/10.64898/2026.05.08.26352549.svg)](https://openscicode.org/badge/doi/10.64898/2026.05.08.26352549)
<!-- oscr-badge:end -->
reStructuredText
.. oscr-badge:start

.. image:: https://openscicode.org/badge/doi/10.64898/2026.05.08.26352549.svg
   :target: https://openscicode.org/badge/doi/10.64898/2026.05.08.26352549
   :alt: OSCR

.. oscr-badge:end
HTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.64898/2026.05.08.26352549"><img src="https://openscicode.org/badge/doi/10.64898/2026.05.08.26352549.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->

If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Report a mismatch between the code and the paper · Report a code error (signed in)

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Report a reproduction failure (signed in)

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.